Cardiopulmonary Bypass (CPB) Pumps and Blood Activation

The recruitment status of this study is unknown because the information has not been verified recently.

Verified September 2005 by University Hospital, Angers.
Recruitment status was Recruiting

Sponsor:

Information provided by:

University Hospital, Angers

ClinicalTrials.gov Identifier:

NCT00187967

First received: September 9, 2005

Last updated: September 24, 2007

Last verified: September 2005

History of Changes

Purpose

Blood activation induced by cardiopulmonary bypass may compromise the postoperative outcome. The goal of this study is to compare blood activation induced by cardiopulmonary bypass performed with centrifugal pump or roller pump in patients undergoing coronary artery surgery.

Condition	Intervention
Cardiopulmonary Bypass Coronary Artery Disease	Device: pumps used for cardiopulmonary bypass

Study Type:	Interventional
Study Design:	Allocation: Randomized Intervention Model: Parallel Assignment Masking: Single Blind Primary Purpose: Treatment
Official Title:	Blood Activation During Cardiopulmonary Bypass Using Roller or Centrifugal Pumps

Resource links provided by NLM:

MedlinePlus related topics: Coronary Artery Disease

U.S. FDA Resources

Further study details as provided by University Hospital, Angers:

Study Start Date:

January 2005

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Male

Criteria

Inclusion Criteria:

Men undergoing coronary artery bypass grafting using cardiopulmonary bypass
Aspirin therapy

Exclusion Criteria:

Redo surgery
Acute coronary syndrome requiring urgent surgery
Oral anticoagulant therapy
Organ dysfunction or chronic inflammatory disease
Surgery other than coronary artery bypass grafting

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00187967

Contacts

Contact: Anthony Bailleul

33-(0)2-41-35-58-91

Locations

France
University Hospital of Angers	Recruiting
Angers, France, 49933
Contact: Christophe Baufreton, MD, PhD 33-(0)2-41-35-45-73 ChBaufreton@chu-angers.fr
Contact: Anthony Bailleul 33-(0)2-41-35-58-91

Sponsors and Collaborators

University Hospital, Angers

Investigators

Principal Investigator:

Christophe Baufreton, MD, PhD

University Hospital of Angers, France

More Information

No publications provided

ClinicalTrials.gov Identifier:	NCT00187967 History of Changes
Other Study ID Numbers:	PHRC 03-03
Study First Received:	September 9, 2005
Last Updated:	September 24, 2007
Health Authority:	France: Ministry of Health

Additional relevant MeSH terms:

Coronary Artery Disease
Myocardial Ischemia
Coronary Disease
Heart Diseases

Cardiovascular Diseases
Arteriosclerosis
Arterial Occlusive Diseases
Vascular Diseases

ClinicalTrials.gov processed this record on May 19, 2013

To Top